Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Ceapro Inc V.CZO

Ceapro Inc. is a Canada-based biotechnology company. The Company is involved in the development of extraction technology and the application of this technology to the production of extracts and active ingredients from oats and other renewable plant resources. Its primary business activities relate to the development and commercialization of natural products for personal care, cosmetic, human, and animal health industries using technology, natural, renewable resources, and developing products, technologies, and delivery systems. The Company's products include a commercial line of natural active ingredients, including beta glucan, avenanthramides (colloidal oat extract), oat powder, oat oil, oat peptides, and lupin peptides, a commercial line of natural anti-aging skincare products, utilizing active ingredients, including beta glucan and avenanthramides and veterinary therapeutic products, including an oat shampoo, an ear cleanser, and a dermal complex/conditioner.


TSXV:CZO - Post by User

Comment by archeo753on Apr 24, 2021 10:36am
93 Views
Post# 33061418

RE:RE:Juvente + Scientific claims validated in a trial = BIG $

RE:RE:Juvente + Scientific claims validated in a trial = BIG $The carrying costs of Juvente do seem pretty steep for the current return but I think a high quality, premium cream with Oat BG, AV and CBD could realy find a market and at a premium price.  Topical cannabis creams at the OCS range from $40 to $100 without the added benefits of AV and oat BG.  Still just potential at this point with Juvente but hopefully some develpoments soon.


Ciao wrote: Oat BG could penetrate deep into the dermis and adding AV was another advantage for a cosmeceutical. These has been incorporated into some of the Juvente skin care products. Without marketing ($$$) and customer acceptance of fhis product, sales last year amounted to $27K and $30K the year before.

Until they find a partner who wants to place bioactives into a product, they should literally leave Juvente on the shelf. They are paying a GM (who sold them Juvente) a salary to look after a line of products that sold $27K worth of product last year and a subsidiary that lost $340K.

When you hear that they will allocate research dollars to their pipeline strategically to preserve capital, one realizes that $340K goes a long way.

prophetoffacts wrote:

With Juvente CZO has demonstrated that it can create an award winning consumer product. Gilles said that it isn't CZO's intention to compete in marketing. CZO's intention is to use Juvente as a delivery platform for unique PGX. Imagine a prescription product:

Juvente +
Proprietary PGX impregnated biopolymers +
Scientific claims validated in a clinical trial

GOLDEN GILLES

Also, imagine a second-generation product that delivered high concentration avenanthramide deeply into the skin with PGX. Second Generation Aveeno? 
 





<< Previous
Bullboard Posts
Next >>